Abstract
Background Myocardial infarction (MI) in the young South Asian population is rising alarmingly. There is an urgent need to identify novel markers to aid early risk estimation. Telomeres are long known to be markers of aging, and shorter telomeres have been reported in cardiovascular diseases (CVDs). Telomeres have been shown to be involved in modulating inflammation and oxidative stresses in other diseases. We aimed to identify the association of telomere length in young MI patients.
Methods & Results In a case-control study of 77 subjects in each group, DNA extraction from peripheral blood leukocytes was carried out and the relative telomere length was estimated by quantitative PCR. The results were adjusted with various demographic parameters like age and gender. The correlation studies were carried out between Telomere length and lipid profile parameters (LDL, HDL, TG, TC), clinical and demographic parameters of the subjects using partial correlations.
Results The relative telomere length was significantly shorter in Young MI patients (31-45 years) compared to matched healthy controls (p<0.0001). Interestingly, in a gender-based comparison, the female patients had shorter telomere length (p<0.01). Correlation analysis of the length with angiographic patterns and even the lipid profile did not reveal significance (p>0.05).
Conclusion Our findings reveal the presence of shorter telomere length in patients of young MI in South Asia. Higher prevalence of stress and other factors may play a role in affecting telomere length. Larger studies are needed to confirm these findings.
- Telomere
- young
- acute myocardial infarction
- South Asian
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The authors confirm that there were no sources of funding for this study.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The authors would be willing to share patient data on a reasonable request.
